Liver Biopsy Clinical Trial
Official title:
Randomized Trial Comparing Endoscopic Ultrasound-guided Liver Biopsy vs. Percutaneous Liver Biopsy
This study is to evaluate and directly compare the technical success, tissue quality, diagnostic efficacy and safety profile of Percutaneous and Endoscopic Ultrasound-guided Liver Biopsy.
Liver biopsy (LB) is essential for the diagnosis and evaluation of a variety of hepatic conditions, such as grading/staging of chronic liver disease secondary to alcohol, non-alcoholic steatohepatitis, viral hepatitis, hemochromatosis, Wilson's disease, cholestatic liver disease, as well as in elucidating the etiology of elevation in liver tests.1 Since it was first performed in 1883, percutaneous (PC) liver biopsy has become routine practice and is usually performed under the guidance of real-time imaging using transabdominal ultrasound (US) or computed tomography (CT).1,2 However, in recent times, liver biopsy has been increasingly performed via transgastric or transduodenal routes under endoscopic ultrasound (EUS) guidance. The perceived advantages of performing EUS-LB compared to PC-LB are the ability to simultaneously assess other organs such as common bile duct and pancreas, access to both left and right lobes of the liver and the routine use of conscious sedation during EUS procedures.3 Although single arm cohort studies and retrospective comparative studies assessing the technical success, tissue quality and safety of these different liver biopsy modalities exist, currently there are no randomized trials comparing PC and EUS-guided LB.4-7 ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00643656 -
Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal Lesion
|
Phase 4 | |
Enrolling by invitation |
NCT04170452 -
Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis Delta
|
||
Recruiting |
NCT03142698 -
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
|
N/A | |
Withdrawn |
NCT03910790 -
Liver Biopsy Using a 19 Gauge Fine Needle Biopsy Needle
|
N/A | |
Recruiting |
NCT03173287 -
Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI
|
N/A | |
Completed |
NCT02620228 -
Identification of Liver Tumours Using BIP - Biopsy System
|
N/A | |
Terminated |
NCT02573545 -
Evaluation of a Support Software in the Planning and Real-time Monitoring of the Insertion of Needles in Interventional Magnetic Resonance Imaging (MRI): Liver Biopsy Case
|
N/A | |
Withdrawn |
NCT04039529 -
Novel Guidance Device for Image Fusion and Needle Guidance in Lung, Liver or Kidney Biopsy
|
N/A | |
Terminated |
NCT03040323 -
Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses
|
Phase 4 | |
Recruiting |
NCT05614973 -
Efficacy and Safety of Percutaneous Liver Biopsy With Needle Tract Plugging on Outpatient Basis
|
N/A |